Loading...
Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer
Tamoxifen is used in the treatment of hormone responsive breast cancer because of its antiestrogenic effect. However, it also has an estrogenic effect on the uterus, thereby increasing the risk of endometrial hyperplasia, endometrial polyp and endometrial neoplasms such as endometrial adenocarcinoma...
Na minha lista:
| Udgivet i: | BMJ Case Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4488633/ https://ncbi.nlm.nih.gov/pubmed/26123463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2015-209981 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|